Order Article Reprints

Cheng M, Lee HH, Chang W-H, Lee N-R, Huang H-Y, Chen Y-J, Horng H-C, Lee W-L, Wang P-H. Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin: A Well-Tolerated and Effective Chemotherapeutic Regimen for First-Line Treatment of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. International Journal of Environmental Research and Public Health. 2019; 16(23):4794. https://doi.org/10.3390/ijerph16234794

Cheng, Min, Howard Hao Lee, Wen-Hsun Chang, Na-Rong Lee, Hsin-Yi Huang, Yi-Jen Chen, Huann-Cheng Horng, Wen-Ling Lee, and Peng-Hui Wang. 2019. "Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin: A Well-Tolerated and Effective Chemotherapeutic Regimen for First-Line Treatment of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer" International Journal of Environmental Research and Public Health 16, no. 23: 4794. https://doi.org/10.3390/ijerph16234794

Cheng, M., Lee, H. H., Chang, W.-H., Lee, N.-R., Huang, H.-Y., Chen, Y.-J., Horng, H.-C., Lee, W.-L., & Wang, P.-H. (2019). Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin: A Well-Tolerated and Effective Chemotherapeutic Regimen for First-Line Treatment of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. International Journal of Environmental Research and Public Health, 16(23), 4794. https://doi.org/10.3390/ijerph16234794